Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acacia Rigidula Found In More Supplements; FDA Warns Six Firms

This article was originally published in The Tan Sheet

Executive Summary

Warning letters to six firms published, like others FDA has submitted since April 2015, explain that acacia rigidula needs approval as a new dietary ingredient, enforcement that the Council for Responsible Nutrition and American Herbal Products Associations commend.

You may also be interested in...



Lack Of Supplement NDI Notification Guidance Not A Market Pass For Industry

Manufacturers, ingredient suppliers and other parties submitting NDI notifications can improve the industry's outlook by "anticipating future products that haven't been brought to market yet" and proposing the highest concentration of an ingredient for the broadest variety of uses, says ODSP senior advisory Cara Welch.

Symrise Touts Green, Biotech Developments In Scent & Care, Raises FY 2022 Growth Target

Symrise AG is now projecting organic sales growth ‘significantly higher’ than 7%, versus a previous estimate of 5% to 7%. The German fragrance and flavors firm, which recorded a 10.2% increase in organic sales in the fiscal 2022 first half, pointed to Hydrolite 8 green and its partnership with biotech Evoxx Technologies among other innovation-minded moves to meet cosmetics demand.

What Slump? Despite Lockdowns, L'Oreal's China Q2 Sales Grow 6% On Supply Agility, Brand Power

Driven by e-commerce and L’Oréal Luxe, which achieved historic market share, L'Oréal SA's results in China helped fuel 13.4% growth of its overall business in the second quarter to 9.3bn.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS108226

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel